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Background: Hepatitis B virus (HBV) encodes an oncogenic factor, HBx, which is a multifunctional protein that can
induce dysfunctional regulation of signaling pathways, transcription, and cell cycle progression, among other
processes, through interactions with target host factors. The subcellular localization of HBx is both cytoplasmic and
nuclear. This dynamic distribution of HBx could be essential to the multiple roles of the protein at different stages
during HBV infection. Transactivational functions of HBx may be exerted both in the nucleus, via interaction with
host DNA-binding proteins, and in the cytoplasm, via signaling pathways. Although there have been many studies
describing different pathways altered by HBx, and its innumerable binding partners, the molecular mechanism that
regulates its different roles has been difficult to elucidate.
Methods: In the current study, we took a bioinformatics approach to investigate whether the viral protein HBx
might be regulated via phosphorylation by an evolutionarily conserved mechanism.
Results: We found that the phylogenetically conserved residues Ser25 and Ser41 (both within the negative
regulatory domain), and Thr81 (in the transactivation domain) are predicted to be phosphorylated. By molecular 3D
modeling of HBx, we further show these residues are all predicted to be exposed on the surface of the protein,
making them easily accesible to these types of modifications. Furthermore, we have also identified Yin Yang sites
that might have the potential to be phosphorylated and O-β-GlcNAc interplay at the same residues.
Conclusions: Thus, we propose that the different roles of HBx displayed in different subcellular locations might be
regulated by an evolutionarily conserved mechanism of posttranslational modification, via phosphorylation.
Keywords: Hepatitis B virus, Hepatitis B virus X protein (HBx), Posttranslational modification, Phosphorylation,
O-β-glycosylationBackground
HBx is the smallest gene of hepatitis B virus (HBV), and
is highly conserved among all eight major genotypes
(A to H) of the virus. The protein is common to all
mammalian members of the Hepadnaviridae family, but
is absent in the avian viruses. The primary amino acids
sequence of HBx spans 154 residues, and is organized
into two functional domains [1]. The N-terminal third is
a negative regulatory domain, whereas the C-terminal
two-thirds act as a transactivation domain. The negative* Correspondence: rodrigo.villanueva@unab.cl
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distribution, and reproduction in any mediumregulatory domain has been mapped to the first fifty
amino acid residues, including a Ser/Pro-rich (residues
21–50) dimerization region that is necessary for HBx
dimerization [2]. The N-terminal region (residues 1–50)
of HBx has been shown to be important for cellular
transformation [3]. The transactivation domain has been
mapped to the region between residues 53 and 142, and
it has been shown that the negative regulatory domain is
dispensable for this function, and actually represses HBx
transactivation [4]. Additionally, the interaction of the
transactivation domain of HBx with XAP-1/UVDDB and
p53 has been mapped to regions 55–101, and 102–136,
respectively [5,6].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Hernández et al. Infectious Agents and Cancer 2012, 7:27 Page 2 of 9
http://www.infectagentscancer.com/content/7/1/27The subcellular localization of HBx seems to be pre-
dominantly cytoplasmic, with a fractional nuclear distri-
bution [7,8]. HBx is primarily localized in the nucleus at
low expression levels but accumulates in the cytoplasm
under conditions of elevated overexpression, indicating
that the subcellular localization of the protein is influ-
enced by its abundance [7,8]. Additionally, high levels of
HBx lead to an abnormal mitochondrial distribution [9].
In the nucleus, HBx has been shown to transactivate a
diverse array of viral and cellular promoters [10]. This
ability suggests that HBx can upregulate the expression
of viral genes by transactivating its own promoters.
Given that HBx does not directly bind to DNA, its abil-
ity to activate transcription of host genes is thought to
take place indirectly by interaction with nuclear tran-
scription factors. Thus, HBx has been reported to associ-
ate with several components of the basal transcriptional
machinery, such as TFIIB, TFIIH, and RBP5, a subunit
of mammalian RNA polymerase [2]. It has also been
demonstrated that HBx is able to bind transcription fac-
tors such as CREB, ATF-2, and AP-2 to modify their ac-
tivities [11,12]. It was recently shown that HBx could
interact and cooperate with CREB-binding protein
(CBP)/p300 to synergistically enhance CREB activity
[13]. Thus, the ability of HBx to interact with cellular
factors may provide a mechanism for its role in tran-
scriptional regulation.
Moreover, different cytoplasmic signal transduction
cascades appear to be affected by HBx, including the
stress-activated protein kinases/NH2-terminal-Jun kin-
ase (SAPK/JNK), extracellular signal-regulated kinase
(ERK), protein kinase B (PKB/Akt), Ras-Raf-mitogen-
activated protein kinase (Ras-Raf-MAPK), the Janus kin-
ase/STAT (JAK/STAT), and the adhesion kinase (FAK)
and proline-rich tyrosine kinase 2 (Pyk2) [11,14]. Fur-
thermore, the Wnt/β-catenin signaling pathway was also
shown to be altered in the presence of HBx. Augmented
expression of β-catenin occurs in 50–70% of human
hepatocarcinoma (HCC) patients [15]. HBx has been
shown to stabilize β-catenin independently of GSK3b in
HCC cell lines [16,17]. Recently, the APC tumor sup-
pressor was identified as a novel binding partner of HBx
indicating its direct involvement in Wnt activation [18].
HBx has been found to be overexpressed in human
HCC, and its overexpression in hepatocyte cultures, and
transgenic mice results in a tumorigenic phenotype in
some model systems [19,20]. It has been suggested that
HBx interacts with the Ras-Raf-MAPK pathway to pro-
mote cell growth [21]. In addition, multiple pathways of
DNA repair are also affected by HBx [22,23]. Moreover,
it was found that both HBx and telomerase were highly
expressed in hepatoma and liver cirrhosis tissues, and
that HBx could upregulate the expression and activity of
hTERT, the catalytic subunit of telomerase [24]. Thesefindings suggest that HBx expression may play a role in
the development of HCC by modulating telomerase
activity.
Given the intricate molecular behavior of HBx includ-
ing its subcellular distribution, the distinct roles dis-
played at different intracellular locations, and its many
interacting partners, it has been difficult to elaborate a
mechanism to explain the regulation of its functions.
Since the primary sequence of the protein does not dis-
play any obvious localization signal, an as yet unexplored
functional alternative is that the protein might be regu-
lated by posttranslational modification.
Phosphorylation of proteins can regulate a viral protein0s
subcellular localization, stability, biochemical and/or en-
zymatic activity, protein/nucleic acids interactions, and
interactions with other cellular and viral partners, as previ-
ously reported for viruses such as rotavirus [25], hepatitis C
virus [26], rabies virus [27], human papillomavirus [28], and
varicella-zoster virus [29], among several others. For hepad-
naviruses, phosphorylation is a fundamental event during
genome replication. The phosphorylation status of the
nucleocapsids has been shown to reflect the maturation
stage of the viral particles [30,31]. On the other hand, there
have been several previous reports investigating the phos-
phorylation of HBx. Since the protein is multifunctional
and distributed in different subcellular locations, it is
assumed that it could be regulated by phosphorylation, and
it has been reported that its overexpression in different sys-
tems yielded phosphorylated HBx [32-34]. Moreover, re-
combinant HBx was found to be phosphorylated in vitro by
protein kinase C (PKC), and mitogen-activated protein kin-
ase (MAPK). Preliminary amino acid analysis showed that
the phosphorylated residues could be serine [35]. Neverthe-
less, a functional role for the phosphorylation of HBx has
not been yet reported.
In addition to phosphorylation by kinases, there is a
different posttranslational modification, known as O-β-
glycosylation that can take place in nearly all eukaryotic
cells. Unlike phosphorylation modulated by host kinases,
O-β-glycosylation is carried out by the activity of a single
enzyme, O-linked N-acetylglucosamine (O-GlcNAc)
transferase (OGT). O-GlcNAc is found on a wide range
of proteins involved in virtually all cellular processes as
well as various human diseases [36,37] including cancer
[38]. In addition, O-GlcNAc can interplay with phos-
phorylation, which, for instance, modulates the stability
and activity of p53 [39]. Furthermore, O-GlcNAc modifi-
cations have been found in several proteins from different
viruses such as the cytomegalovirus basic phosphoprotein
UL32 (pp150) [40], the adenovirus fiber protein [41], the
baculovirus gp41 protein [42], and the nonstructural rota-
virus NSP5 (NS26) protein [43] as well as the capsid
protein from plum pox virus [44]. The biological relevance
of these modifications is not yet known. However,
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proteins are also phosphoproteins, as in the cases of
CMV pp150, and rotavirus NSP5. It remains to be deter-
mined if there is some interplay between the two types of
modifications.
Phosphorylation and O-GlcNAc modifications on the
same or neighboring Ser and Thr residues are known to
occur in several nuclear and cytosolic proteins. This is
known as the Yin Yang hypothesis, and the Ser and Thr
residues involved in this interplay are considered Yin
Yang sites. Typically, Yin Yang sites may compete for
similar Ser or Thr residues or they might alter the sub-
strate specificity of nearby sites by steric or electrostatic
effects [45-48].
In the current article, our group has taken a bioinfor-
matics approach to investigate whether the viral protein
HBx might be regulated via phosphorylation by a phylo-
genetically conserved mechanism. The results obtained
by this kind of approach should help in designing future
new research lines, in order to expand our understand-
ing on both the biology and virology of HBx protein.
Methods
HBV sequences
As previously reported, we have amplified, and
sequenced several full-length HBV DNAs from human
samples corresponding to isolates from genotype F [49].
The PCR amplified DNA corresponding to isolate
HCUCH4 (accession number HM585186) was sub-
cloned. One representative clone (Isolate 4.5) was fur-
ther subjected to two-strand full-length sequencing, and
has been shown to be able to replicate in cultured cells
(data not shown). The sequence of the HBx protein from
isolate 4.5 used in this study is “MAA RLC CQL DPA
RDV LCL RPV SAE SCG RSL SGS LGA VSP PSP SAV
PAD DGS HLS LRG LPV CSF SSA GPC ALR FTS ARR
MET TVN APR SLP TVL HKR TLG LSG RSM TWI
KEY IKD CVF KDW EEL GEE IRL KVF VLG GCR
HKL VCS PAP CNF FTS A”. Further results about the
functionality of clone isolate 4.5 will be published
elsewhere.
In the current study, HBx protein sequences from the
eight major genotypes of HBV (A to H) were included,
considering only full-length published isolates. Homology
searches and sequence alignments (Figure 1B) were made
with two protein sequences from genotype A (AP007263
and GQ414522), three sequences from genotype B
(AB602818, AB554017, and AB540582), four sequences
from genotype C (AB644286, AB560661, AB554022, and
AB554014), four sequences from genotype D (AB554023,
AB267090, AB554016, and AB554024), four sequences
from genotype E (AP007262, AB106564, AB091255, and
AB091256), four sequences from genotype G (GU565217,
AB064316, AP007264, and AB064314), three sequencesfrom genotype H (AB516395, AP007261, and AB298362),
and two sequences from genotype F (AB166850, and
AB214516). The sequence of HBx from HCUCH4
(ADV59932) differs from that of isolate 4.5 at amino acid
residue 109 because of an E - > K substitution, respectively.
Homology analysis, and multiple alignments of protein
sequences were carried out with ClustalW at the Pôle
Bioinformatique Lyonnais web site (pbil.univ-lyon1.fr/).
Post-translational modification predictions
For all the prediction analyses, we used the sequence of
the HBx protein corresponding to clone isolate 4.5 as a
reference.
To analyze the phosphorylation potential of the HBx
protein, we utilized several servers on the web such as
NetPhos 2.0, DISPHOS 1.3, PPRED, and Phos3D [50-53].
These are neural networks-based programs that predict
potential sites of serine, threonine, and tyrosine phosphor-
ylation in polypeptides (Table 1). The minimum threshold
value used to predict phosphorylation is 0.5 on both Net-
Phos 2.0, and DISPHOS. On PPRED, the analysis was
made with default parameters. The Phos3D results were
obtained considering a decision value > 0 as a positive
prediction.
Specific kinases for phosphorylation positions in HBx
were also predicted by NetPhosK 1.0, KinasePhos, PPSP,
and GPS 2.1 [54-57]. These servers predict kinase spe-
cific acceptor substrates including serine, threonine, and
tyrosine residues.
Potential O-β-GlcNAc modification sites were pre-
dicted by the server. This program can predict potential
phosphorylation sites as well as predict Yin Yang sites
with a highly uneven threshold that is adjusted in ac-
cordance with amino acid surface accessibility [58].
Protein structure analysis
Since there is no template model of HBx available, we
designed an ab-initio model using the software I-TASSER
(zhanglab.ccmb.med.umich.edu/I-TASSER/; [59]). Data in
sequence form was uploaded to the server. The model
with the highest C-score was selected for further analyses.
To view, and analyze the 3D structure of HBx, both
RasMol v. 2.7.5.2., and MVP (Macromolecular Visualization
and Processing, v. 1.0) software were used. To assess
whether the predicted serine and threonine residues have
surface accessibility for posttranslational modifications,
NetSurfP was utilized [60].
Results
The hepatitis B virus HBx protein includes a primary se-
quence of 154 amino acid residues, and has been dissected
into two functional regions, as shown in Figure 1A. The
N-terminal third (the first fifty amino acid residues) is a
negative regulatory domain, whereas the C-terminal two-
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Figure 1 Hepatitis B virus X protein (HBx). A) Schematic representation of HBx domain organization. As shown, HBx is functionally organized
into an N-terminal, and a C-terminal domain. The N-terminal third of HBx corresponds to the negative regulatory domain, which includes a Ser/
Pro-rich region. The remaining C-terminal two-thirds of the protein comprises the transactivation domain. B) Multiple sequence alignment of HBx
proteins from all main HBV genotypes using ClustalW. Accession numbers are indicated in the left column, followed by the HBV genotype of
each isolate. Conserved Ser, Thr, and Tyr residues are shown in bold across the sequences. At the bottom of the alignment, the consensus
sequence is marked by an asterisk, conserved substitutions by a double dot, and a semiconserved substitution by a single dot.
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domain includes a Ser/Pro-rich (residues 21–50) dimerization
region, whereas the transactivation domain has been
mapped to the region between residues 53 and 142 [1,2].
Thus, since the protein might be subjected to complex
regulation to display all its roles within the nucleus as well
as in the cytoplasm, we searched for a phylogenetically con-
served mechanism of regulation such as phosphorylation.Table 1 Bioinformatics tools used for prediction
Name Technique Residues
Phosphorylation
NetPhos 2.0 ANN 9-33
DISPHOS 1.3 LR 25
PPRED PSSM, SVM 7-15
Phos3D SVM 13
Kinases
NetPhosK 1.0 ANN 9-33
KinasePhos SVM 9
PPSP BP 9
GPS 2.1 PSSM, GA 3-31
Techniques: ANN: Artificial neural network; LR: Logistic regression; SVM: Support vec
PSSM: Position-specific scoring matrix; BP: Bayesian probability; GA: Genetic algorithThe HBx protein from clone isolate 4.5 was aligned to-
gether with 26 other HBx protein sequences including
all main HBV genotypes (genotypes A-H). Conserved
serine, threonine, and tyrosine residues were determined
across all main genotypes, as shown in Figure 1B. It is
clear from the figure that serines 25, 41, 54, 75, 104, and
153; threonines 74, 81, 97, and 106; tyrosine 111 are all
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via phosphorylation. Interestingly, both serine residues
25 and 41 are included in the negative regulatory do-
main, and within the dimerization region of HBx,
whereas all the other conserved positions are included
in the transactivation domain of the protein.
To predict potential phosphorylation sites among the
conserved serine, threonine, and tyrosine residues of
HBx, we used several servers available on the web
(Table 1). Prediction results are shown on Table 2. The
combined results from NetPhos 2.0 and DISPHOS 1.3
indicated that the serine residues, the prediction of the
phosphorylation scores was Ser75 > Ser41 > Ser25. Ser54
presented a score close to threshold. However, consider-
ing the spatial context, Phos3D predicted that only
Ser25 and Ser41 would be phosphorylated. These data
were further confirmed by NetSurfP 1.1, which predicted
that both Ser25 and Ser41 are exposed residues. As indi-
cated above, both Ser25 and Ser41 are located within the
Ser/Pro-rich region in the negative regulatory domain of
HBx. Among HBx threonine residues, both NetPhos 2.0
and DISPHOS 1.3 predicted the phosphorylation of Thr81.
These data were further confirmed by Phos3D, and accord-
ing to the analysis of the NetSurfP 1.1, this residue is
expected to be exposed. Interestingly, among the conserved
threonine residues in HBx, phosphorylation of Thr81 will
take place within the transactivation domain of the protein.










S25 0.961 0.762 ― + E
S41 0.983 0.930 + + E
S54 0.652 0.672 ― ― E
S75 0.984 0.672 ― ― B
S153 0.005 0.187 ― ― E
Threonines
T74 0.147 0.115 ― ― B
T81 0.947 0.823 + + E
T97 0.017 0.085 ― ― E
T106 0.524 0.113 ― ― E
Tyrosines
Y111 0.031 0.062 ― ― B
Netphos: threshold > 0.5; DISPHOS: threshold >0.5; PPRED, Phos3D: parameters as d
B: buried surface; O-β-GlcNAc: threshold as default.furthermore this position is expected to be buried, and is,
therefore, not predicted to be phosphorylated.
Different kinases may be implicated in the phosphoryl-
ation of serine, threonine and tyrosine residues. Several
protein kinases are also involved in phosphorylating two
or more kinds of residues. The kinases predicted to be
involved in phosphorylation of conserved residues of
HBx are shown in Table 2. As shown, several kinases are
predicted to phosphorylate the same phosphorylation
site since the local amino acid sequence around the
phosphoacceptor residue can be recognized by them.
The prediction results for O-linked glycosylation sites
showed that HBx exhibits the potential for O-β-GlcNAc
modification, as shown in Figure 2. The conserved HBx
Ser and Thr residues predicted to be O-β-GlcNAc modi-
fied are Ser41, Ser153, Thr74, Thr81, and Thr97. On the
other hand, the conserved HBx Ser, and Thr residues
predicted to be positive sites for Yin Yang modification
are Ser41 and Thr81, as indicated in Figure 2. In
addition to the positive Yin Yang sites, in several
instances, the same Ser and Thr residues show a very
high potential for phosphorylation, and also show a po-
tential very close to the specific threshold value for O-β-
glycosylation as predicted by existing methods. Such
sites are termed false-negative (FN) Yin Yang sites, when
they are evolutionary conserved, as on these sites the
OGT enzyme and kinases may have similar accessibility
for inducing posttranslational modifications of interestNetPhosK 1.0 KinasePhos PPSP GPS 2.1 YinOYang
1.2
CKI ― ― TKL MLK ILK ―
P38MAPK GSK3
cdk5
cdc2 MAPK KIS CMGC MAPK
ERK
+
CKI PKC ― MAPKKK ― ―
― ― ― AGC PKC
CAMK
―
― ― ― AGC GRK TKL ―
PKC ― PKR ― ―
― PKA MAPKKK CAMK DAPK
LKB
+
PKG PKA ILK TLK MLK ILK ―
― ― ― AGC SGK
CAMKL
―
― ― ― TK PDFGR Eph ―









Figure 2 Predicted O-glycosylation and Yin Yang sites on the HBx protein. The O-β-GlcNAc modification potential of each Ser, and Thr
residues is shown by green vertical lines, and the light blue horizontal wavy line indicates the threshold for modification potential. The Yin Yang
sites that were positively predicted are shown by red asterisks at the top. The profile was obtained with server YinOYang 1.2, using the HBx
sequence of our HBV isolate 4.5 as a reference. The numbers at the top of lines of O-glycosylation potential indicate the positions of conserved
HBx Ser, Thr or Tyr residues. As shown, Ser25 represents a FN Yin Yang site.
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Ser25 as a FN Yin Yang site (Figure 2).
In order to analyze the location of the conserved Ser,
and Thr residues predicted to be phosphorylated within
HBx, we drew a 3D model of the protein. We also
assessed the possible surface accessibility of HBx for
these posttranslational modifications. In the model
shown in Figure 3, and consistent with the results shown
above, we found that Ser25, Ser41, and Thr81 are all
exposed residues within the 3D model of HBx. This in-
formation depicts that these Ser and Thr positions ex-
hibit ready access to these types of modifications.Thr81
Ser25
Ser41
Figure 3 Homology 3D modeling of HBx. The HBx sequence of
our isolate 4.5 used as a reference was submitted to server I-Tasser
for protein structure prediction. Out of five models developed by
the server, we selected the model with the highest C-value. To view
and analyze HBx 3D structure, both RasMol v. 2.7.5.2., and MVP
(Macromolecular Visualization and Processing, v. 1.0) software were
used. The positions of Ser25, Ser41, and Thr81 are shown in the
model.Discussion
Chronic hepatitis B virus infection has been strongly
associated with the development of hepatocellular car-
cinoma. HBV encodes an oncogenic factor, HBx, which
is a multifunctional regulator that modulates signal
transduction pathways, gene transcription, cell cycle pro-
gression, protein degradation, apoptosis, and genetic sta-
bility through direct and indirect interactions with target
cell factors [2]. The subcellular localization of HBx is
primarily cytoplasmic, with a small fraction in the nu-
cleus [7,8]. The dynamic allocation of HBx could be im-
portant for the multiple roles of this protein at different
stages in the HBV life cycle. Transactivational functions
of HBx may be exerted both in the nucleus, via interac-
tions with host DNA-binding proteins, and in the cyto-
plasm, via signaling pathways [2]. Although there have
been many studies describing different pathways altered
by HBx, and its innumerable binding partners, the mo-
lecular mechanism that regulates its different roles has
been difficult to elucidate.
In order to analyze whether HBx might be regulated
by a mechanism that involves a posttranslational modifi-
cation such as phosphorylation, we took a bioinformatics
approach, searching for an evolutionarily conserved
mechanism of regulation. In strong support of our ana-
lysis, earlier observations have indicated that HBx was
phosphorylated upon overexpression of the protein in
different systems [32-35]. In the current study, to predict
the likehood of phosphorylation on phylogenetically
conserved Ser, Thr or Tyr HBx residues, we combined
the utilization of multiple neural network-based soft-
wares that predict potential phosphorylation sites with
the use of several servers that predict kinase-specific ac-
ceptor substrates together with molecular 3D modeling
of HBx. Our analysis indicated that Ser25, Ser41, and
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conserved mechanism. These positions were all pre-
dicted to have high potentials for phosphorylation by
servers such as NetPhos 2.0, and DISPHOS 1.3, and the
results were confirmed by servers such as PPRED. Pre-
dictions of phosphorylation on Ser25, Ser41, and Thr81
were further verified by the Phos3D program, which
considers information in a spatial context. NetSurfP ana-
lysis which predicts surface accessibility, and secondary
structure within an amino acid sequence indicated that
all three residues were exposed.
In addition to phosphorylation by kinases, we also
checked predictions of O-β-glycosylation sites on HBx.
It has been demonstrated that phosphorylation and
O-GlcNAc modifications on the same or neighboring
Ser and Thr residues occur in several nuclear and cyto-
plasmic proteins, and phosphorylation and O-β-GlcNAc
modifications are thought to establish an interplay in
what are considered Yin Yang sites [45-48]. Yin Yang
sites may compete for similar Ser or Thr residues or
they might alter the substrate specificities of nearby
positions by steric or electrostatic effects [48]. Ser41 and
Thr81 are conserved HBx Ser and Thr residues pre-
dicted to be positive sites for Yin Yang modification. In
addition, we found that Ser25 was predicted to be a
false-negative (FN) Yin Yang sites. Ser25 was not pre-
dicted to be O-β-GlcNAc, although it was close to
threshold value, and showed very high potential for
phosphorylation. In addition, we found that the con-
served Ser25, Ser41, and Thr81 are all exposed residues
within the predicted 3D model of HBx. This information
carries the implication that these Ser and Thr positions
are readily accessible to these modifications.
Together, our results lead us to speculate that the con-
served HBx residues Ser25, Ser41, and Thr81 may be
potential phosphorylation sites that can regulate the
roles of the HBx protein. Interestingly, both the Ser25
and Ser41 residues are located in the N-terminal, nega-
tive regulatory domain, and within the Ser/Pro-rich
dimerization region, whereas Thr81 is located within the
transactivation, C-terminal domain of HBx. Whether
phosphorylation of each of these residues actually acti-
vates/represses several HBx protein functions remains to
be experimentally determined, for example by targeted
mutagenesis.
Phosphorylation events are one way in which animal
viruses can make use of cellular signaling pathways for
their own benefits, and the literature is well provided
with different kinds of examples. In the case of HIV-1,
the p6 protein contains the late domain involved in virus
budding. This domain was determined to be phosphory-
lated by different kinases [62]. Further analysis identified
a specific residue, Thr23, which is phosphorylated by
MAPK, and ERK-2, both in vitro and in vivo [63]. Onthe other hand, the rubella virus capsid protein is phos-
phorylated at various sites by unknown kinases, and
these phosphorylations are important for optimal viral
replication [64,65].
A number of cellular enzymes that have been implicated
in nucleic acid metabolism, such as the DNA-dependent
RNA polymerases I and II [66,67], DNA polymerase α
[68], and DNA topoisomerase IIα [69], are actually phos-
phoproteins, whose functions are regulated by phosphoryl-
ation, via kinases. Several viral enzymes are also regulated
by phosphorylation. The RNA polymerase of the dengue
virus (type 2) is phosphorylated on a serine residue by ca-
sein kinase II, and this phosphorylation regulates the inter-
action of the polymerase with other viral proteins, and the
function of the viral replicase complex [70]. Furthermore, a
phosphorylation in the N-terminal region of the RNA poly-
merase 2a protein from cucumber mosaic virus (CMV) by
a 60 kDa protein kinase was shown to inhibit the inter-
action of the 2a polymerase with the 1a protein, whose
interaction is essential for the genome replication of this
plant virus [71].
Recently, Khattar et al. published a report where the
Ser31 residue of HBx was shown to be phosphorylated
by Akt 1 kinase [72]. The interaction between HBx and
Akt was essential for Akt signaling, and it enhanced the
oncogenic potential of HBx. However, a simple examin-
ation of HBx amino acid sequences from different iso-
lates indicates that HBx Ser31 is not a conserved
residue. Whereas HBV isolates from genotypes A, C, D,
E and H all contain the Ser31 residue, some isolates
from genotypes F and G do not, and isolates from geno-
type B all contain a Pro31 residue. It is clear from this
analysis that phosphorylation of Ser31 does not reflect a
conserved mechanism of regulation of HBx, and further,
it might indicate why some HBV isolates are more onco-
genic or pathogenic than others.
Conclusions
Taken together, our analyses and results indicated that
the roles of HBx might be regulated by an evolutionarily
conserved mechanism of posttranslational modification,
via phosphorylation of Ser25, Ser41, and/or Thr81.
Future perspectives
Bioinformatics offers different ways for looking at pro-
blems in biology, analyzing data to generate new know-
ledge that might be useful in diverse fields such as
biological pathway regulation, and drug design, among
others. In the case of the viral HBx protein, utilizing bio-
informatics specific software, we have found several
amino acid residues that exhibit a clear potential for
being phosphorylated by cellular protein kinases. How-
ever, the information presented in the current study will
need to be experimentally validated both for individual
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context of an HBV infection. We hope our study will
contribute to further understanding the regulation of the
viral HBx protein.
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